Royal Bank Of Canada Issues Pessimistic Forecast for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its price objective decreased by equities researchers at Royal Bank Of Canada from $19.00 to $17.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 42.74% from the stock’s current price.

A number of other brokerages have also recently commented on ACHC. Raymond James Financial set a $17.00 price target on shares of Acadia Healthcare in a research report on Wednesday, December 3rd. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday, December 3rd. KeyCorp decreased their target price on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 3rd. Leerink Partners reissued a “market perform” rating and issued a $14.00 price target (down from $25.00) on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Finally, Bank of America cut Acadia Healthcare from a “neutral” rating to an “underperform” rating and reduced their price objective for the company from $21.50 to $13.00 in a research note on Wednesday, December 3rd. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Acadia Healthcare has an average rating of “Hold” and a consensus target price of $18.64.

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $11.91 on Wednesday. Acadia Healthcare has a fifty-two week low of $11.43 and a fifty-two week high of $45.61. The firm’s fifty day moving average price is $14.93 and its 200-day moving average price is $20.05. The stock has a market cap of $1.10 billion, a P/E ratio of 10.18, a price-to-earnings-growth ratio of 3.08 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The business had revenue of $851.57 million for the quarter, compared to the consensus estimate of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The company’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter last year, the business posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, equities research analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently made changes to their positions in the business. Wellington Management Group LLP boosted its holdings in shares of Acadia Healthcare by 11.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,423,548 shares of the company’s stock valued at $233,327,000 after buying an additional 993,205 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Acadia Healthcare by 7.8% in the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after acquiring an additional 681,278 shares in the last quarter. Abrams Bison Investments LLC lifted its position in Acadia Healthcare by 22.3% during the 3rd quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after acquiring an additional 800,000 shares during the period. UBS Group AG boosted its stake in Acadia Healthcare by 8.8% during the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after acquiring an additional 350,484 shares in the last quarter. Finally, State Street Corp grew its holdings in Acadia Healthcare by 3.2% in the second quarter. State Street Corp now owns 3,095,775 shares of the company’s stock worth $70,243,000 after purchasing an additional 95,670 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.